-+ 0.00%
-+ 0.00%
-+ 0.00%

Cybin publishes corporate presentation; pipeline advances HLP003 in Phase 3 for adjunctive MDD and HLP004 targets GAD with positive Phase 2 data

Reuters·03/27/2026 14:16:55

Please log in to view news